Document is current
Any future updates will be listed below
-
Authors
Zhou, Changwu
Lu, Xin
Wang, Yi
Qian, Xianling
Yang, Chun
Zeng, Mengsu https://orcid.org/0000-0002-2759-4844
-
Funding
Funding for this research was provided by:
Clinical Research Plan of SHDC (SHDC2020CR1029B)
National Natural Science Foundation of China (82171897)
Shanghai Municipal Key Clinical Specialty (shslczdzk03202)
Clinical Research Project of Zhongshan Hospital, Fudan University (2020ZSLC61)
- License Information
-
More Information
Article History
Received: 16 March 2022
Revised: 13 June 2022
Accepted: 26 July 2022
First Online: 17 August 2022
Declarations
:
: The scientific guarantor of this publication is Mengsu Zeng.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: Two of the authors (Changwu Zhou and Xin Lu) have significant statistical expertise.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in a prior study entitled “MRI features predict the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection” on the publication of European Radiology.
: • retrospective• observational• performed at one institution
